Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

Bullboard (NDAQ:LMNL)

View:

Comment by GunnerGon Dec 06, 2021 2:44pm

RE:RE:Do I hear .80's

I gave you the date (aug 9th), seriously. Also, I stated that the Nas could have waved the requirements as they did for 9/11. Click Here Scroll down to Aug 9

Discussion

Comment by GunnerGon Dec 06, 2021 1:47pm

RE:why get rid of your chief scientist it's clear they didn't i

Senior leadership role not research. Hired to get the Ryplazim BLA through regulatory approval process. Good luck on your lawsuit. What is it costing you? LAVAL, QC, ROCKVILLE, MD ...more

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by hankmanon Dec 06, 2021 1:43pm

RE:Do I hear .80's

Gunner, froma quick look at the 6 month chart for LMNL, it looks like it has not been over $4 since the end of June '21. That is now over 5months, so why have they not yet recieved a notice fron ...more

Discussion

Post by 4Justiceon Dec 06, 2021 12:53pm

Reject from NASDAQ

If you think about what's going on, you should conclude that the best outcome for the Thomson family, their financial arm Thomvest and their tax free company SALP is to be rejected from the NASDAQ ...more

162

Discussion

Post by edroseon Dec 06, 2021 12:13pm

why get rid of your chief scientist it's clear they didn't i

intend to do research

117

Discussion

Comment by GunnerGon Dec 06, 2021 12:09pm

RE:they got rid of lynne gagnon and hired daniels so

She isn't a scientist why bring her name up. Her skills are dealing with regulators.

Discussion

Post by edroseon Dec 06, 2021 11:15am

they got rid of lynne gagnon and hired daniels so

it would look good she doesn't have any experience and can't compared her to doctor gagnon all planned JUDGE WILL CLEARLY SEE WHAT THEY DID TO SEVERAL HUNDRED INVESTORS AND ...more

172

Discussion

Post by GunnerGon Dec 06, 2021 10:56am

Do I hear .80's

This thing is dropping faster than I thought it could, wow. Last date above $4.00 was August 9, 2021. LMNL would get notice after 30 days and have 90 days to fix the issue which is days away I ...more

227

Discussion

Comment by 4Justiceon Dec 06, 2021 10:31am

RE:Moira Daniels VP Regulatory affairs is out since september

If it was important to announce his hiring in November 2019, why not have announced his departure last September in a Press release or in the Q3 MD&A filed November 15 ? Still hiding move !

Discussion

Post by 4Justiceon Dec 06, 2021 10:03am

Moira Daniels VP Regulatory affairs is out since september

Experience Head Of Regulatory Affairs, EMEA Company Name BridgeBio Full-time Dates EmployedSep ...more

129

Discussion

Post by stockbuphoonon Dec 06, 2021 9:44am

$0.95 already… Thomvest making it work

Management doesn't have any milestones after selling off everything except small molecule 4050 / Fezagrapras. Thomvest have scripted this fall perfectly as they did in 2018. What are these 200 ...more

118

Post by edroseon Dec 06, 2021 9:21am

the fact that they left 10 million loan with several covena

collateral and ip attached to this small loan will come out during discovery listen to 2019 agm lawyers have copy of audio when they where asked why did you keep this loan galbraith answered ...more

138